![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
RCC Update from ESMO 2023 (COR2ED The Heart of Medical Education) View |
![]() |
ESMO 2023: RENOTORCH Assesses Toripalimab and Axitinib in RCC (GU Oncology Now) View |
![]() |
RCC Panel Reacts to LITESPARK-005 Data Presented at ESMO 2023 (GU Oncology Now) View |
![]() |
Focus on Nonclear Cell RCC: Frontline Treatment Options, Research Limitations, and More (GU Oncology Now) View |
![]() |
Second-Line Treatment Options for RCC (GU Oncology Now) View |
![]() |
RCC Panel Shares What They Are Most Excited About in the Field (GU Oncology Now) View |
![]() |
Highlights on sotorasib plus panitumumab in KRAS G12C-mutated mCRC: The CodeBreak 300 study (European Society for Medical Oncology (ESMO)) View |
![]() |
Panel Discusses the Value of Immunotherapy in Frontline RCC (GU Oncology Now) View |
![]() |
Dr. Laurence Albiges on Results of Arm B5 of KEYMAKER-U03B for Belzutifan Plus Lenvatinib in accRCC (GU Oncology Now) View |
![]() |
Dr. Rana McKay on Upcoming Prostate Cancer ESMO Data at The Uromigos: Live u0026 Unplugged (GU Oncology Now) View |